ACP
Acuta Capital Partners’s Tourmaline Bio TRML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.54M | Sell |
283,682
-143,200
| -34% | -$2.29M | 6.33% | 5 |
|
|
2025
Q1 | $6.49M | Buy |
426,882
+75,040
| +21% | +$1.14M | 7.53% | 3 |
|
|
2024
Q4 | $7.14M | Buy |
351,842
+19,747
| +6% | +$400K | 7.18% | 3 |
|
|
2024
Q3 | $8.54M | Buy |
332,095
+62,481
| +23% | +$1.61M | 6.92% | 3 |
|
|
2024
Q2 | $3.47M | Buy |
269,614
+8,506
| +3% | +$109K | 2.92% | 12 |
|
|
2024
Q1 | $5.98M | Buy |
261,108
+29,226
| +13% | +$669K | 3.88% | 9 |
|
|
2023
Q4 | $6.07M | Buy |
+231,882
| New | +$6.07M | 3.42% | 12 |
|